Marked neurological and immunological improvement in refractory eosinophilic granulomatous polyangiitis after treatment with mepolizumab, an anti‐interleukin‐5 antibody: A case report

Authors :: Manato Yasuda
Tomoki Suichi
Sonoko Misawa
Atsuhiko Sugiyama
Satoshi Kuwabara
Source :: Clinical and Experimental Neuroimmunology. 11:181-184
Publication Year :: 2020
Publisher :: Wiley, 2020.

Subjects :: biology
business.industry
Immunology
Neuroscience (miscellaneous)
Immunology and Microbiology (miscellaneous)
Refractory
Eosinophilic
medicine
biology.protein
Neurology (clinical)
Antibody
business
Mepolizumab
Interleukin 5
After treatment
medicine.drug

Full Text Access

Tools